In a study with a NOD model mouse of type 1 diabetes treated with resveratrol to prevent and treat type 1 diabetes, it was discovered that the expression of CCR6 decreased and the presence of CCR6+ IL-17 producing cells decreased in the pancreas after treatment. This evidence concerns the gene IL17A and type 1 diabetes mellitus.